MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2478/jccm-2024-0045

Медицинская библиотека · Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2025

The effect of pre-existing sarcopenia on outcomes of critically ill patients treated for COVID-19.

Bradier Thomas, Grigioni Sébastien, Savoye-Collet Céline, Béduneau Gaétan, Carpentier Dorothée, Girault Christophe, Grall Maximillien, Jolly Grégoire, Achamrah Najate, Tamion Fabienne, Demailly Zoé

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Sarcopenia, defined by a loss of skeletal muscle mass and function, has been identified as a prevalent condition associated with poor clinical outcome among critically ill patients. This study aims to evaluate the impact of pre-existing sarcopenia on outcomes in critically ill patients with acute respiratory failure (ARF) due to COVID-19.

MATERIAL AND

METHODS

A retrospective study was carried out on COVID-19 patients admitted to intensive care. Pre-existing sarcopenia was assessed using early CT scans. Clinical outcomes, including duration of high-flow oxygenation (HFO), mechanical ventilation (MV), length of hospital stay (LOS) and ICU mortality, were evaluated according to sarcopenia status.

RESULTS

Among the studied population, we found a high prevalence (75 patients, 50%) of pre-existing sarcopenia, predominantly in older male patients. Pre-existing sarcopenia significantly impacted HFO duration (6.8 (+/-4.4) vs. 5 (+/-2.9) days; p=0.005) but did not significantly affect MV requirement (21 (28%) vs. 23 (37.3%); p=185), MV duration (7 vs. 10 days; p=0.233), ICU mortality (12 (16%) vs. 10 (13.3 %); p=0.644) or hospital LOS (27 vs. 25 days; p=0.509). No differences in outcomes were observed between sarcopenic and non-sarcopenic obese patients.

CONCLUSIONS

Pre-existing sarcopenia in critically ill COVID-19 patients is associated with longer HFO duration but not with other adverse outcomes. Further research is needed to elucidate the mechanisms and broader impact of sarcopenia on septic critically ill patient outcomes.

Для цитирования: Bradier Thomas, Grigioni Sébastien, Savoye-Collet Céline, Béduneau Gaétan, Carpentier Dorothée, Girault Christophe, Grall Maximillien, Jolly Grégoire, Achamrah Najate, Tamion Fabienne, Demailly Zoé. The effect of pre-existing sarcopenia on outcomes of critically ill patients treated for COVID-19.. Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures). 2025. DOI: 10.2478/jccm-2024-0045.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.